NOVEL SUBSTANCE TO AID IN THE REMINERALIZATION OF TEETH

Information

  • Research Project
  • 6073457
  • ApplicationId
    6073457
  • Core Project Number
    R43DE013281
  • Full Project Number
    1R43DE013281-01A1
  • Serial Number
    13281
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/2000 - 24 years ago
  • Project End Date
    10/31/2002 - 22 years ago
  • Program Officer Name
    ZHANG, GUO HE
  • Budget Start Date
    9/15/2000 - 24 years ago
  • Budget End Date
    10/31/2002 - 22 years ago
  • Fiscal Year
    2000
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    9/14/2000 - 24 years ago

NOVEL SUBSTANCE TO AID IN THE REMINERALIZATION OF TEETH

The overall goal of this project is to develop a novel substance as an aid in the remineralization of teeth. Dental caries continues to be a serious public health and economic burden in spite of the prevalence of worldwide exposure to fluoride. Even though the incidence of caries has dropped over the last twenty years, it remains a major problem as a recent study found that 45.3% of children in the U.S. ages 5 - 17 scored positive for caries in their permanent dentition. This study will evaluate the ability of a unique apatite-forming substance to stimulate the remineralization of teeth through the development of large crystallite structures. In order to demonstrate feasibility of this project, we will evaluate this unique technology to (1) determine its effect on the in vitro development of caries and (2) determine its effect on caries inhibition in an in vivo rodent model. PROPOSED COMMERCIAL APPLICATIONS: Over $37 billion was spent on dental services in the U.S. alone in 1992. Over half of this amount was spent on the prevention of tooth decay, single-tooth restoration, and the replacement of teeth. In addition to caries, this technology may have an impact on periodontal disease, osteoporosis, and alveolar bone loss.

IC Name
NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH
  • Activity
    R43
  • Administering IC
    DE
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    107000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    121
  • Ed Inst. Type
  • Funding ICs
    NIDCR:107000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOMEDICAL DEVELOPMENT CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN ANTONIO
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    782163610
  • Organization District
    UNITED STATES